| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/17/2003 | WO2003031595A2 Molecules for disease detection and treatment |
| 04/17/2003 | WO2003031590A2 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 04/17/2003 | WO2003031589A2 Peptides and related compounds having thrombopoietic activity |
| 04/17/2003 | WO2003031588A2 Hepatitis c virus vaccine |
| 04/17/2003 | WO2003031583A2 Generation of virus-like particles by vsv |
| 04/17/2003 | WO2003031578A2 Mammalian c-type lectins |
| 04/17/2003 | WO2003031577A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | WO2003031576A2 Antisense modulation of inhibitor-kappa b kinase-gamma expression |
| 04/17/2003 | WO2003031573A2 Toll-like receptor 3 signaling agonists and antagonists |
| 04/17/2003 | WO2003031570A2 Method for cloning and expression of bseri restriction endonuclease and bseri methylase in e. coli |
| 04/17/2003 | WO2003031568A2 Intracellular signaling molecules |
| 04/17/2003 | WO2003031567A2 Precursor conversion screening methods |
| 04/17/2003 | WO2003031476A1 Antibody of human origin for inhibiting thrombocytes aggregation |
| 04/17/2003 | WO2003031475A2 Antibodies against kdr, their production and uses |
| 04/17/2003 | WO2003031472A2 Insulin mimetic amino acid sequences |
| 04/17/2003 | WO2003031471A1 Methods and compositions for production and purification of recombinant staphylococcal enterotoxin b (rseb) |
| 04/17/2003 | WO2003031470A2 Dna-expression construct for treatment of infections with leishmaniasis |
| 04/17/2003 | WO2003031469A2 Means for improving immune response |
| 04/17/2003 | WO2003031468A1 Therapeutic and diagnostic molecules that are capable of interacting with socs proteins |
| 04/17/2003 | WO2003031466A2 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/17/2003 | WO2003031464A2 Remodeling and glycoconjugation of peptides |
| 04/17/2003 | WO2003031462A2 Nogo receptor-mediated blockade of axonal growth |
| 04/17/2003 | WO2003031459A2 Modulation of the expression of genes dependent on stat-1 |
| 04/17/2003 | WO2003031063A2 Device for holding a substance library carrier |
| 04/17/2003 | WO2003031054A2 Arrays having clustered arrangements and methods of making and using them |
| 04/17/2003 | WO2003031031A1 Method for analyzing mass spectra |
| 04/17/2003 | WO2003031014A1 Separation medium, its preparation and its use |
| 04/17/2003 | WO2003030946A1 Regulation of insulin production |
| 04/17/2003 | WO2003030945A1 Cationic lipids suitable for gene transfer |
| 04/17/2003 | WO2003030944A2 Inhibition of stat-1 |
| 04/17/2003 | WO2003030943A1 Compositions comprising hydroxyapatite useful for the administration of therapeutic agents |
| 04/17/2003 | WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | WO2003030922A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 04/17/2003 | WO2003030833A2 Angiopoietin-2 specific binding agents |
| 04/17/2003 | WO2003030832A2 Antisense therapy using oligonucleotides that target human kinesin genes for treatment of cancer |
| 04/17/2003 | WO2003030826A2 Antisense modulation of insulin-like growth factor binding protein 5 expression |
| 04/17/2003 | WO2003030824A2 Methods and compositions for treating dermal lesions |
| 04/17/2003 | WO2003030720A2 Materials and methods for preventing or reducing scar formation |
| 04/17/2003 | WO2003030639A2 Methods for growing and imprinting fish using an odorant |
| 04/17/2003 | WO2003030636A1 Rodent with urinary disturbance and method of constructing the same, and method of screening remedy for urinary disturbance using the rodent |
| 04/17/2003 | WO2003030624A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 04/17/2003 | WO2003030623A2 System for manipulating nucleic acids |
| 04/17/2003 | WO2003030617A2 Antisense modulation of creb expression |
| 04/17/2003 | WO2003030616A2 21132, a human g-protein coupled receptor family member and uses therefor |
| 04/17/2003 | WO2003030612A2 Methods for modulating activity of the fxr nuclear receptor |
| 04/17/2003 | WO2003004630A3 Method for determining the genetic predisposition of a mammal for its milk fat content and/or for its intramuscular fat content |
| 04/17/2003 | WO2003000707A3 Antisense modulation of superoxide dismutase 1, soluble expression |
| 04/17/2003 | WO2002103021A3 Method for increasing the carotenoid-content in transgenic plants |
| 04/17/2003 | WO2002097130A3 Microstructures and use thereof for the directed evolution of biomolecules |
| 04/17/2003 | WO2002094863A3 INTERFERON-α INDUCED GENE |
| 04/17/2003 | WO2002086441A3 Amplification and detection of mycoplasma pneumoniae |
| 04/17/2003 | WO2002086064A3 Inducible expression of transfected genes |
| 04/17/2003 | WO2002085943A3 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
| 04/17/2003 | WO2002085930A3 Immunomodulating agents from parasitic worms and method for isolation thereof |
| 04/17/2003 | WO2002085104A3 Methods of transforming plants |
| 04/17/2003 | WO2002083883A3 Human phosphodiesterase 9a isoform |
| 04/17/2003 | WO2002083727A3 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 04/17/2003 | WO2002083072A3 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 04/17/2003 | WO2002081706A3 Regulation of human phosphatase-like protein |
| 04/17/2003 | WO2002079405A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 04/17/2003 | WO2002076486A3 Histidine-rich glycoprotein |
| 04/17/2003 | WO2002074965A3 Characterization of the i-spoml endonuclease from fission yeast |
| 04/17/2003 | WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 04/17/2003 | WO2002068468A3 Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof |
| 04/17/2003 | WO2002064804A3 A bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes |
| 04/17/2003 | WO2002064615A3 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 04/17/2003 | WO2002061070A3 Environmentally regulated genes, involved in the virulence of streptococcus suis |
| 04/17/2003 | WO2002059151A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 04/17/2003 | WO2002057664A3 Bacillus thuringiensis insecticidal proteins |
| 04/17/2003 | WO2002057416A3 Improved biochip |
| 04/17/2003 | WO2002055709A3 Rhodococcus cloning and expression vectors |
| 04/17/2003 | WO2002053752A3 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 04/17/2003 | WO2002051990A3 Proteases of endogenous retroviruses, substrates thereof and method for screening inhibitors |
| 04/17/2003 | WO2002051237A9 Helicobacter proteins, nucleic acids and uses thereof |
| 04/17/2003 | WO2002050289A9 Methods for the production of multimeric proteins, and related compositions |
| 04/17/2003 | WO2002050284A3 Oxidoreductases |
| 04/17/2003 | WO2002046436A9 Plasmid vectors |
| 04/17/2003 | WO2002046428A3 Novel human kinase and polynucleotides encoding the same |
| 04/17/2003 | WO2002039923A3 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis |
| 04/17/2003 | WO2002033094A1 Antibody inhibiting vplf activity |
| 04/17/2003 | WO2002033085A3 Wisp polypeptides and therapeutical applications thereof |
| 04/17/2003 | WO2002032960A3 Methods of selecting compounds for modulation of bladder function |
| 04/17/2003 | WO2002032291A9 Imaging of enzymatic activity |
| 04/17/2003 | WO2002031168A3 Minimal adenoviral vector and recombinant vaccines based thereon |
| 04/17/2003 | WO2002030974A3 Proteins and nucleic acids encoding same |
| 04/17/2003 | WO2002029036A3 Lipid metabolism enzymes |
| 04/17/2003 | WO2002028901A3 Seven-transmembrane (7tm) receptors and uses thereof |
| 04/17/2003 | WO2002028900A3 Tach: new tnf-receptor family nucleic acids and polypeptides |
| 04/17/2003 | WO2002027327A3 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome |
| 04/17/2003 | WO2002026960A3 Modulation of gene expression using localization domains |
| 04/17/2003 | WO2002024891A3 B7-like molecules and uses thereof |
| 04/17/2003 | WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 04/17/2003 | WO2002018579A3 57242, a novel human g protein-coupled receptor family member and uses therefor |
| 04/17/2003 | WO2002018576A3 Compositions and methods relating to lung specific genes |
| 04/17/2003 | WO2002018575A3 Genes expressed in the cell cycle |
| 04/17/2003 | WO2002014502A3 Sclerotinia-inducible genes and promoters and their uses |
| 04/17/2003 | WO2002012341A3 Her-2/neu fusion proteins |
| 04/17/2003 | WO2002010402A3 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 04/17/2003 | WO2002008400A3 25233, a human aminotransferase and uses therefor |
| 04/17/2003 | WO2002006523A3 Method for detecting pre-disposition to hepatotoxicity |